Bulky "gatekeeper" residue changes the cosubstrate specificity of aminoglycoside 2-phosphotransferase IIa

4Citations
Citations of this article
14Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The aminoglycoside 2-phosphotransferases APH(2)-IIa and APH(2)-IVa can utilize ATP and GTP as cosubstrates, since both enzymes possess overlapping but discrete structural templates for ATP and GTP binding. APH(2)-IIIa uses GTP exclusively, because its ATP-binding template is blocked by a bulky tyrosine gatekeeper residue. Replacement of the gatekeeper residues M85 and F95 in APH(2)-IIa and APH(2)-IVa, respectively, by tyrosine does not significantly change the antibiotic susceptibility profiles produced by the enzymes. In APH(2)-IIa, M85Y substitution results in an10-fold decrease in the Km value of GTP and an320-fold increase in the Km value of ATP. In APH(2)-IVa, F95Y substitution results in a modest decrease in the Km values of both GTP and ATP. Structural analysis indicates that in the APH(2)-IIa M85Y mutant, tyrosine blocks access of ATP to the correct position in the binding site, while the larger nucleoside triphosphate (NTP)-binding pocket of the APH(2)-IVa F95Y mutant allows the tyrosine to move away, thus giving access to the ATP-binding template. Copyright © 2013, American Society for Microbiology. All Rights Reserved.

Cite

CITATION STYLE

APA

Bhattacharya, M., Toth, M., Smith, C. A., & Vakulenko, S. B. (2013). Bulky “gatekeeper” residue changes the cosubstrate specificity of aminoglycoside 2-phosphotransferase IIa. Antimicrobial Agents and Chemotherapy, 57(8), 3763–3766. https://doi.org/10.1128/AAC.00381-13

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free